Hyperbilirubinemia type 1

Hyperbilirubinemia Type 1, also known as Crigler-Najjar syndrome Type 1, is a rare genetic disorder characterized by the body's inability to properly process bilirubin, a yellow compound that is formed by the breakdown of red blood cells. This condition leads to an excessive accumulation of bilirubin in the blood, resulting in jaundice (yellowing of the skin and eyes). Hyperbilirubinemia Type 1 is an autosomal recessive disorder, meaning that an individual must inherit two defective genes, one from each parent, to be affected.

Causes

Hyperbilirubinemia Type 1 is caused by mutations in the UGT1A1 gene, which encodes the enzyme uridine diphosphate-glucuronosyltransferase 1A1 (UGT1A1). This enzyme plays a critical role in the conversion of bilirubin into a form that can be eliminated from the body through bile. Mutations in the UGT1A1 gene result in reduced or absent activity of this enzyme, leading to the accumulation of unconjugated bilirubin in the blood.

Symptoms

The primary symptom of Hyperbilirubinemia Type 1 is persistent jaundice, which can appear shortly after birth. Unlike physiological jaundice, which is common in newborns and resolves without treatment, the jaundice associated with Hyperbilirubinemia Type 1 persists and can lead to severe complications. High levels of unconjugated bilirubin can be toxic to the brain, a condition known as kernicterus, which can result in permanent neurological damage.

Diagnosis

Diagnosis of Hyperbilirubinemia Type 1 typically involves measuring the levels of bilirubin in the blood, with a particular focus on the unconjugated (indirect) bilirubin levels. Genetic testing can confirm mutations in the UGT1A1 gene, providing a definitive diagnosis.

Treatment

Treatment for Hyperbilirubinemia Type 1 is aimed at reducing the levels of bilirubin in the blood to prevent kernicterus. Treatment options include phototherapy, where the skin is exposed to specific types of light that help break down bilirubin; and plasmapheresis, a procedure that filters the blood to remove bilirubin. In severe cases, a liver transplant may be considered as a curative treatment.

Prognosis

The prognosis for individuals with Hyperbilirubinemia Type 1 varies. With early and aggressive treatment, the risk of brain damage and other complications can be minimized. However, the condition requires lifelong management, and individuals with Hyperbilirubinemia Type 1 are at risk for developing bilirubin-induced neurological damage if their bilirubin levels are not adequately controlled.

Hyperbilirubinemia type 1 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia